Quest Diagnostics Inc
(DGX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 872,000 | 987,000 | 560,000 | 1,230,000 | 1,158,000 |
| Receivables | 1,438,000 | 1,473,000 | 1,255,000 | 1,382,000 | 1,520,000 |
| Inventories | 208,000 | 205,000 | 199,000 | 223,000 | 223,000 |
| TOTAL | $2,741,000 | $2,854,000 | $2,146,000 | $2,999,000 | $3,058,000 |
| Non-Current Assets | |||||
| PPE Net | 1,707,000 | 1,634,000 | 1,622,000 | 1,624,000 | 1,627,000 |
| Investments And Advances | 141,000 | 124,000 | 111,000 | 527,000 | 521,000 |
| Intangibles | 8,262,000 | 8,209,000 | 8,217,000 | 8,011,000 | 8,040,000 |
| Other Non-Current Assets | 760,000 | 751,000 | 765,000 | 770,000 | 780,000 |
| TOTAL | $10,870,000 | $10,718,000 | $10,715,000 | $10,932,000 | $10,968,000 |
| Total Assets | $13,611,000 | $13,572,000 | $12,861,000 | $13,931,000 | $14,026,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,000 | 1,000 | 2,000 | 2,000 | 2,000 |
| Accounts payable and accrued liabilities | 1,600,000 | 1,610,000 | 1,404,000 | 1,559,000 | 1,633,000 |
| TOTAL | $1,753,000 | $1,759,000 | $1,551,000 | $1,707,000 | $1,776,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,010,000 | 4,006,000 | 4,008,000 | 4,010,000 | 4,013,000 |
| Other Non-Current Liabilities | 1,342,000 | 1,353,000 | 1,343,000 | 1,403,000 | 1,391,000 |
| TOTAL | $5,375,000 | $5,381,000 | $5,370,000 | $5,434,000 | $5,441,000 |
| Total Liabilities | $7,128,000 | $7,140,000 | $6,921,000 | $7,141,000 | $7,217,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 119,455 | 122,675 | 122,181 | 130,638 | 133,455 |
| Common Shares | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 |
| Retained earnings | 7,649,000 | 7,333,000 | 10,246,000 | 9,690,000 | 9,303,000 |
| Other shareholders' equity | 25,000 | 27,000 | 31,000 | 14,000 | 29,000 |
| TOTAL | $6,483,000 | $6,432,000 | $5,940,000 | $6,790,000 | $6,809,000 |
| Total Liabilities And Equity | $13,611,000 | $13,572,000 | $12,861,000 | $13,931,000 | $14,026,000 |